VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $650 | +33.7% | 150,399 | +103.7% | 0.01% | +50.0% |
| Q2 2023 | $486 | -99.5% | 73,822 | +631.0% | 0.00% | +300.0% |
| Q3 2022 | $100,000 | -93.4% | 10,099 | -92.7% | 0.00% | -94.4% |
| Q2 2022 | $1,506,000 | +82.1% | 138,176 | +88.9% | 0.02% | +80.0% |
| Q1 2022 | $827,000 | +17.6% | 73,131 | +63.2% | 0.01% | +42.9% |
| Q4 2021 | $703,000 | +92.1% | 44,815 | +163.1% | 0.01% | +75.0% |
| Q2 2021 | $366,000 | -55.2% | 17,034 | -68.7% | 0.00% | -66.7% |
| Q1 2021 | $817,000 | +383.4% | 54,402 | +322.1% | 0.01% | +500.0% |
| Q4 2020 | $169,000 | -61.9% | 12,887 | -52.2% | 0.00% | -75.0% |
| Q4 2019 | $443,000 | – | 26,968 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |